Search

everythinglearnresearchcommunity

for

Search:↓

Some lesser-known causes of PCOS include autoimmune issues, genetic mutations, and changes in the body's microbiome.

Certain immune cells in the skin release a protein that stops hair growth by keeping hair stem cells inactive.

Hormones affect skin aging, and treatments targeting hormonal balance may improve skin health.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Hormones and genes affect hair growth and male baldness.

Acne is significantly influenced by genetics, and understanding its genetic basis could lead to better, targeted treatments.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Multi-omics techniques help understand the molecular causes of androgenetic alopecia.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Androgens may block hair growth signals, targeting this could treat hair loss.

Four genetic risk spots found for hair loss, with WNT signaling involved and a link to curly hair.

Male pattern baldness involves hormones and cell signals affecting hair growth.

The article concludes that the wool follicle is a valuable model for studying tissue interactions and has potential for genetic improvements in wool production.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Hairless protein is crucial for healthy skin and hair, and its malfunction can cause hair loss.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

The research provides insights into hair follicle growth in forest musk deer by identifying key genes and pathways involved.

Natural products may help treat skin inflammation from abnormal adrenal hormones.

Male-pattern hair loss is largely influenced by genetics, with key genes identified.

Effective PCOS treatments require targeting specific signaling pathways.

Certain gene variations in AKT2 are more common in women with PCOS and are linked to higher levels of specific hormones and symptoms.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Melatonin affects many body functions beyond sleep by interacting with specific receptors in various tissues.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

Palmitoyl tetrapeptide-20 may help reduce hair greying and increase melanin production.

Young women in West Bengal, India, with PCOS often have estrogen resistance, leptin receptor issues, folate deficiency, T2DM, and acanthosis, commonly linked to obesity.